期刊文献+

骨质疏松症治疗药物研究概述 被引量:4

Development of Drugs in Treating Primary Osteoporosis
下载PDF
导出
摘要 原发性骨质疏松症是以骨量减少、骨质微观结构退化为特征的一种全身性疾病。其主要并发症是各种脆性骨折,也是引起病残和死亡的主要原因。骨质疏松症已经成为严峻的公共卫生及社会问题。通过查阅国内外有关治疗骨质疏松症药物的文献报道,对近几年来抗骨质疏松症药物的研究进展进行综述,为临床防治骨质疏松症的医务工作人员做一有益参考。 Primary osteoporosis is a systemic disease characterized by osteopenia and degeneration of hone mierostrueture. Its main complication are kinds of brittle bone fraeture,whiek also is the main reason resulting in disability and death. Osteoporosis has become the severe publie health and social problem. This article aims to providing a reference to clinical prevention and treatment of asteoporosis based on the related document of primary osteoporosis.
出处 《医学综述》 2009年第10期1523-1525,共3页 Medical Recapitulate
关键词 骨质疏松 药物 骨密度 Osteoporosis Drugs Bone mass density
  • 相关文献

参考文献18

  • 1刘淑娟,程爱斌.雌激素替代治疗绝经妇女骨质疏松症临床观察[J].中国煤炭工业医学杂志,2003,6(4):367-368. 被引量:5
  • 2Reeve J, Mitchell A, Tellez M, et al. Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis:prediction of longterm responses in spine and femur[ J]. J Bone Miner Metab ,2001,19(2) : 102-114. 被引量:1
  • 3Gold DT, Silverman SL. Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis? [ J]. Curr Osteoporos Rep,2007,5 ( 1 ) :3-7. 被引量:1
  • 4Russell RG. Bisphosphonates: mode of action and pharmacology [ J]. Pediatrics,2007,119 ( Suppl 2) : S150-S162. 被引量:1
  • 5Rizzoli R. Longterm outcome of weekly bisphosphonates [ J ]. Clin Orthop Relat Res,2006,443(2):61-65. 被引量:1
  • 6Hashimoto J. Therapeutic agents for disorders of bone and calcium metabolism I : bandronate [ J ]. Clin Calcium,2007,17 ( 1 ) : 11-17. 被引量:1
  • 7Snag K, Lindsay R, Kriegman A, et al. A single zoledronic acid Infusion reduced bone resorption markers more rapidly than weekly oral alendrenate in postmenopausal women with low bone mineral density [ J ]. Bone, 2007,40 (5) : 1238 -1243. 被引量:1
  • 8Lindsay R, Zhou H, Cosman F, et al. Effects of a one-month treatment with PTH (1-34)on bone formation on cancellous, endocortical, and periosteal Surfaces of the human ilium [ J ]. J Bone Miner Res,2007,22(4) :495-502. 被引量:1
  • 9Thomas T. Intermittent parathyroid hormone therapy to increase bone formation [ J ]. Joint Bone Spine,2006,73 ( 3 ) : 262-269. 被引量:1
  • 10Chuengsamarn S, Suwanwalaikom S. Comparing the effect of short term post meal and bedtime calcium supplementation on the C-terminal telopeptide crosslinks and PTH levels in postmenopausal osteopenic women[ J]. J Med Assoc Thai,2005,88 (1) :S12-S20. 被引量:1

二级参考文献41

共引文献75

同被引文献24

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部